Peptron, Inc. (KOSDAQ:087010)
South Korea · Delayed Price · Currency is KRW 280,500
-5,500 (-1.92%)
At close: Dec 4, 2025
Peptron Company Description
Peptron, Inc. engages in the development of peptide-based medicines.
The company’s technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug.
It develops PAb 001 for cancer therapy; SR-Exenatide (PT320) for Parkinson’s and other neurodegenerative disease; SR-Octreotide for the treatment of acromegaly; and Dernak filler for bioequivalence.
Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.
Peptron, Inc.
| Country | South Korea |
| Founded | 1997 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Ho-Il Choi |
Contact Details
Address: 37-24, Yuseong-daero 1628 beon-gil Daejeon, 34054 South Korea | |
| Phone | 82 4 2360 8880 |
| Website | peptron.co.kr |
Stock Details
| Ticker Symbol | 087010 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7087010005 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Ho-Il Choi | Chief Executive Officer |